Two new studies at The Texas Heart Institute test a new ECG integrated watch and scale for patients with AFib

The Texas Heart Institute recently opened enrollment for two clinical trials to evaluate the performance of devices that integrate ECG apps. In both studies, participants must have a history of atrial fibrillation and meet the additional inclusion criteria.

Doctors have used electrocardiograms (ECGs) to help detect atrial fibrillation (AFib) for decades. This life-saving test can catch AFib before it leads to a stroke. A doctor recommends an ECG if patients notice heart palpitations, chest pain or shortness of breath, lightheadedness, and extreme fatigue and routinely performs the test for patients at risk of heart disease or those with a family history of it. New wearable watches and body scale devices are integrating ECG monitors that could help inform patients of looming heart troubles.

The Texas Heart Institute Center for Cardiovascular Care’s Dr. Briana Costello is the principal investigator of a study designed to test the Withings HWA10 with embedded Withings ECG-app in the automatic detection of atrial fibrillation and sinus rhythm.

“…wearable and smart scale technologies have the potential to change lives by improving health, increasing fitness, and enhancing performance, but they can also detect deadly heart problems before it is too late.” – Dr. Briana Costello

The Center’s Dr. Alexander Postalian is serving as the principal investigator of a study designed to demonstrate the performance of the Withings body scan scale (WBS08) in the automatic identification of atrial fibrillation and sinus rhythm.

 

Contact the Research Team Directly SIGN UP

---